STOCK TITAN

Vanguard disaggregates holdings; Integer Holdings (NASDAQ: ITGR) shows 0 shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Integer Holdings Corp ownership filing: The Vanguard Group amended its Schedule 13G to report 0 shares beneficially owned, representing 0% of the common stock. The amendment notes an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries/divisions to report beneficial ownership separately.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports zero beneficial ownership after internal realignment.

The filing states 0 shares beneficially owned and 0% of the class as reported in the amendment. It attributes the change to an internal realignment on January 12, 2026, with subsidiaries reporting on a disaggregated basis per SEC Release No. 34-39538.

Cash‑flow treatment and any redistributed holdings are not described in the excerpt; subsequent filings by Vanguard subsidiaries may show where previously aggregated positions now appear.

Amendment clarifies reporting structure, not a trading event.

This Schedule 13G/A is administrative: it documents reporting changes under SEC Release No. 34-39538 and lists ownership as 0 shares. The statement emphasizes separate reporting by subsidiaries that pursue the same investment strategies post‑realignment.

Material impact depends on subsidiary filings that reassign prior holdings; monitor future Schedule 13 filings by Vanguard affiliates for relocated positions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does Vanguard report for Integer Holdings (ITGR)?

Vanguard reports 0 shares beneficially owned of Integer Holdings common stock, equal to 0% of the class. The amendment reflects an internal realignment that moved prior aggregated holdings to subsidiaries reporting separately.

Why did Vanguard file Amendment No. 15 for ITGR?

The filing amends reporting following an internal realignment on January 12, 2026, causing certain Vanguard subsidiaries/divisions to report beneficial ownership separately under SEC Release No. 34-39538.

Does the amendment indicate Vanguard sold ITGR shares?

No. The amendment documents reporting structure changes and lists 0 shares beneficially owned; it does not state any sales transaction or proceeds in the provided excerpt.

Will Vanguard subsidiaries report ITGR holdings separately?

Yes. The amendment states certain subsidiaries or business divisions will report beneficial ownership separately and no longer be aggregated with The Vanguard Group, Inc., per the cited SEC release.

Who signed the Schedule 13G/A for Vanguard?

The filing is signed by Ashley Grim, Head of Global Fund Administration, with the signature date listed as 03/27/2026.
Integer Hldgs Corp

NYSE:ITGR

View ITGR Stock Overview

ITGR Rankings

ITGR Latest News

ITGR Latest SEC Filings

ITGR Stock Data

2.99B
33.92M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
PLANO